Johnson & Johnson develops medicines and medical devices. The Innovative Medicine segment covers immunology, cancer and neuroscience, and the MedTech segment supplies surgical tools, orthopaedic implants, heart treatments and contact lenses used by hospitals and clinics. In 2023 J&J spun off its consumer brands, such as Band-Aid and Tylenol, into a separate business named Kenvue. Brothers Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson started the firm in New Brunswick, New Jersey, in 1886.
Johnson & Johnson is listed on the New York Stock Exchange under the ticker JNJ. It is part of the Healthcare sector, in the Drug Manufacturers - General industry, and is based in New Brunswick, United States.
This page opens SwinGrowth's analysis of Johnson & Johnson from its real daily price history: an entry zone, a stop loss and two price targets for a swing trade, with its trend, RSI, moving averages, volume, support and resistance.
Other Healthcare stocks on SwinGrowth: AbbVie, Eli Lilly and Merck.
Education, not financial advice. SwinGrowth does not predict prices or tell you to buy or sell.